February 26, 2021February 24, 2021
A Farewell Note to My Beloved Readers
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
So, the time has come. Here I am, three years after I sat down for the first time to write ... Read more
February 15, 2021February 11, 2021
A Light-giver Shares a Lesson in Emotional Honesty
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
Have you ever noticed how the people with the most light to give are often those who have endured the ... Read more
February 1, 2021January 27, 2021
Embarking on a New Chapter While Cherishing the Value of Community
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
It’s surreal to ponder that our world has been living through a pandemic for a year now. That we’ve endured ... Read more
December 14, 2020December 9, 2020
Shedding My Sickness While Acknowledging Its Eternal Impact
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
Just before the world changed overnight in March, I wrote a column titled “The Paradox of Healing.” In it, I ... Read more
November 16, 2020November 12, 2020
Sometimes Everything Works Out All Right
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
The other day, I chanced upon a poem called “Sometimes” that stopped me in my tracks and penetrated right through ... Read more
September 28, 2020September 24, 2020
Let’s Not Forget the Superheroes
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
Lately, in the midst of all the insanity going on in the world and the ensuing, albeit dispiriting, headlines covering ... Read more
September 14, 2020September 10, 2020
Frozen Toes and Sleepless Nights: The Reality of Being a Cancer Survivor
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
For the past week, I have been living in what I can only describe as a state of unrelenting exhaustion. ... Read more
August 31, 2020August 27, 2020
Can a Break From Routine Induce Healing?
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
This is a question I found myself pondering the other week as I locked up my little flat and escaped ... Read more
August 17, 2020August 13, 2020
Reflections on My ‘Re-birthday’ and the Past Year of Recovery
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
By the time this column is published, the one-year anniversary of my lifesaving stem cell transplant will have come and ... Read more
July 27, 2020July 23, 2020
This Year Has Taught Me Gratitude
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
This week I’ve felt completely at a loss over what to write about. It happens sometimes. Usually there’s something on ... Read more
July 13, 2020July 9, 2020
Total Happiness Is Unobtainable, and That’s OK
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
I recently came to the realization that none of us will ever be totally happy. Upbeat way to start a ... Read more
June 29, 2020June 25, 2020
As I Befriend My Fear of Relapse, Fear Loses Its Power
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
Being a cancer survivor is a complicated thing. It’s a lot of conflicting experiences at once. It’s walking down the ... Read more

February 22, 2019

FDA OKs Phase 1 Trial to Test TJC4 in Solid Tumors, Lymphoma

News

I-Mab Biopharma is planning the first-in-human U.S. clinical study evaluating the safety, tolerability, and efficacy of its investigational candidate TJC4 as a treatment for solid tumors and lymphoma. The Phase ... Read more

February 21, 2019

First Patient Dosed in Trial of ADCT-402 for Advanced Non-Hodgkin’s Lymphoma

News

A Phase 1 trial testing the combination of ADCT-402 (loncastuximab tesirine) with Imfinzi (durvalumab) in multiple types of advanced non-Hodgkin’s lymphoma has dosed the first patient. The study (NCT03685344) is for adults with ... Read more

February 19, 2019

Poteligeo Proves Safe, Effective for ATL Patients in Clinical Setting

News

Poteligeo (mogamulizumab), an approved treatment for relapsed or refractory adult T-cell leukemia-lymphoma (ATL) patients in Japan, is also safe and effective in a real-world clinical setting, a postmarketing surveillance study found. ... Read more

$Opdivo Effective for Relapsed/Refractory Classical Hodgkin’s Lymphoma, Meta-analysis Suggests$

February 18, 2019

Opdivo Effective for Relapsed/Refractory Classical Hodgkin’s Lymphoma, Meta-analysis Suggests

News

Immune checkpoint inhibitor Opdivo (nivolumab) appears to be more effective at treating patients with relapsed or refractory classical Hodgkin’s lymphoma than other therapies, a meta-analysis suggests. The study, “Efficacy of ... Read more

February 15, 2019

European Commission Approves Adcetris/Chemo Combo for Some Hodgkin’s

News

The European Commission has approved the used of Adcetris (brentuximab vedotin) in combination with standard chemotherapy for the initial treatment of advanced CD30-positive Hodgkin’s lymphoma patients in the European Union, Norway, Liechtenstein and Iceland. The approval, ... Read more

February 14, 2019

FDA Update Shows 457 Cases of ALCL Linked to Breast Implants

News

The number of reported cases of anaplastic large cell lymphoma associated with breast implants (BIA-ALCL) has risen to 457, according to a 2018 update from the U.S. Food and Drug Administration ... Read more

February 13, 2019February 14, 2019

Stand Up To Cancer’s ‘Dream Team’ to Investigate Devimistat Combo Therapy for T-cell Lymphoma

News

Rafael Pharmaceuticals‘ devimistat (CPI-613) — which targets the metabolic alterations in cancer cells — will be studied as part of a combination therapy for the treatment of T-cell lymphoma, the company announced. ... Read more

February 13, 2019February 14, 2020

X4 Pharmaceuticals Launches Phase 1b Trial Testing Mavorixafor-Imbruvica Combo for Waldenström’s Macroglobulinemia

News

X4 Pharmaceuticals has launched a Phase 1b trial to assess the safety and tolerability of mavorixafor (X4P-001), in combination with Imbruvica (ibrutinib), for the treatment of people with Waldenström’s macroglobulinemia ... Read more

February 12, 2019

Experts Propose New Consensus Scale for CAR T-cell Therapy Toxicities

News

The American Society for Blood and Marrow Transplantation (ASBMT) proposed a new consensus scale for toxicities associated with CAR T-cell therapies to better categorize their severity in both the hospital setting ... Read more

February 11, 2019

Rituxan Plus Chemo Fails to Benefit Newly Diagnosed Primary CNS Lymphoma Patients in Clinical Trial

News

Adding Rituxan (rituximab) to standard first-line chemotherapy did not improve disease outcomes for people with primary central nervous system (CNS) lymphoma in a Phase 3 clinical trial, results show. The ... Read more

February 8, 2019

U.K. Institute Recommends Kymriah for Adults with Aggressive DLBCL

News

The U.K.’s National Institute for Health and Care Excellence (NICE) has recommended that Kymriah (tisagenlecleucel) be offered to patients with difficult-to-treat diffuse large B-cell lymphoma (DLBCL) through the Cancer Drugs Fund. Specifically, this Novartis-developed therapy ... Read more

February 8, 2019February 5, 2019

The Joy of a New Oncologist

Columns, Things That Give Me Hope - a Column by Bob McEachern

I seem to have bad luck with oncologists. I was diagnosed with follicular lymphoma a little over 11 years ago. But in the last five years, I have had five ... Read more

A Farewell Note to My Beloved Readers

A Light-giver Shares a Lesson in Emotional Honesty

Embarking on a New Chapter While Cherishing the Value of Community

Shedding My Sickness While Acknowledging Its Eternal Impact

Sometimes Everything Works Out All Right

Let’s Not Forget the Superheroes

Frozen Toes and Sleepless Nights: The Reality of Being a Cancer Survivor

Can a Break From Routine Induce Healing?

Reflections on My ‘Re-birthday’ and the Past Year of Recovery

This Year Has Taught Me Gratitude

Total Happiness Is Unobtainable, and That’s OK

As I Befriend My Fear of Relapse, Fear Loses Its Power